Users Online: 93
Home Print this page Email this page
Home About us Editorial board Search Browse articles Submit article Ahead of Print Instructions Subscribe Contacts Login 

    Article Cited by others


Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers

Sanaei Masumeh, Kavoosi Fraidoon

Year : 2019| Volume: 8| Issue : 1 | Page no: 63-63

   This article has been cited by
1 Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro
Saira Justin,Jochen Rutz,Sebastian Maxeiner,Felix K.-H. Chun,Eva Juengel,Roman A. Blaheta
International Journal of Molecular Sciences. 2020; 21(15): 5582
[Pubmed]  [Google Scholar] [DOI]
2 A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
Bailin He,Qiang Wang,Xiaoli Liu,Ziyuan Lu,Jiaochan Han,Chengyun Pan,Bing Z. Carter,Qifa Liu,Na Xu,Hongsheng Zhou
Biomedicine & Pharmacotherapy. 2020; 129: 110390
[Pubmed]  [Google Scholar] [DOI]
3 Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells
Mona Dawood,Mohamed Elbadawi,Madeleine Böckers,Gerhard Bringmann,Thomas Efferth
Biomedicine & Pharmacotherapy. 2020; 129: 110454
[Pubmed]  [Google Scholar] [DOI]
4 Epigenetic Research in Stem Cell Bioengineering—Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials
Claudia Dompe,Krzysztof Janowicz,Greg Hutchings,Lisa Moncrieff,Maurycy Jankowski,Mariusz J. Nawrocki,Malgorzata Józkowiak,Paul Mozdziak,Jim Petitte,Jamil A. Shibli,Marta Dyszkiewicz-Konwinska,Malgorzata Bruska,Hanna Piotrowska-Kempisty,Bartosz Kempisty,Michal Nowicki
Cancers. 2020; 12(4): 1016
[Pubmed]  [Google Scholar] [DOI]
5 Recent Update of HDAC Inhibitors in Lymphoma
I-Chung Chen,Bidyadhar Sethy,Jing-Ping Liou
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
6 Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Loredana Cappellacci,Diego R. Perinelli,Filippo Maggi,Mario Grifantini,Riccardo Petrelli
Current Medicinal Chemistry. 2020; 27(15): 2449
[Pubmed]  [Google Scholar] [DOI]
7 Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla,Lívia Fratini,Paula S. Cardoso,Carolina Nör,André T. Brunetto,Algemir L. Brunetto,Caroline Brunetto de Farias,Mariane Jaeger,Rafael Roesler
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed]  [Google Scholar] [DOI]
8 Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
Kishor Pant,Estanislao Peixoto,Seth Richard,Sergio A. Gradilone
Cells. 2020; 9(3): 780
[Pubmed]  [Google Scholar] [DOI]
9 Gelated vorinostat with inner-lysosome triggered release for tumor-targeting chemotherapy
Changyong Guo,Qirong Wang,Xingjie Zhang,Fengkun Lu,Miao Sun,Peiyu Zeng,Linhong Sun,Lan She,Bingkai Wang,Yunchang Zhang,Chen Wang,Zhiqiang Ma,Feng Yang
Colloids and Surfaces B: Biointerfaces. 2020; : 111144
[Pubmed]  [Google Scholar] [DOI]
10 Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes
Paul Peixoto,Céline Grandvallet,Jean-Paul Feugeas,Michaël Guittaut,Eric Hervouet
Cells. 2019; 8(12): 1656
[Pubmed]  [Google Scholar] [DOI]
11 The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker
Feifei Yang,Na Zhao,Yunjie Hu,Cheng-Shi Jiang,Hua Zhang
Chemistry & Biodiversity. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article